Patients requiring multifactorial risk management : Individuals with multiple cardiovascular risk factors may benefit from the pleiotropic effects of GLP-1 therapy, including blood pressure reduction, weight loss, and lipid improvements
In 2011, a study revealed that the administration of phenformin in combination with 2-deoxyglucose can prevent the development of lactic acidosis, reducing toxicity
In fact, the ratio of reduced glutathione to oxidized glutathione within cells is often used scientifically as a measure of cellular toxicity
Researchers also noted that improved metabolic balance could enhance treatment response to DMARDs, offering a synergistic effect that benefits both cardiovascular and inflammatory outcomes
A weight loss plateau during GLP-1 treatment is a common occurrence and usually happens as your body adapts to the changes
One last thing to note - there are different forms of L-carnitine, one that is better for performance and recovery and one that has additional cognitive benefits so be sure you understand your goals for supplementing
